Traders work on the floor of the New York Stock Exchange on Feb. 4, 2025. NYSE U.S. stock futures were little changed Wednesday night after the major averages posted back-to-back winning sessions. Futures tied to the Dow Jones Industrial Average were marginally higher. S&P 500 futures and Nasdaq 100 futures were both trading around flat….
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market rotation: The Dow was the big winner Monday, tracking for its first close above 44,000. However, the pressure on the S & P 500 and…
President Donald Trump looks on as his nominee for the chairman of the Federal Reserve Jerome Powell takes to the podium during a press event in the Rose Garden at the White House, November 2, 2017 in Washington, DC. Drew Angerer | Getty Images Talk about an eventful week. Normally, when the Fed cuts interest…
(Bloomberg) — AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns over a Chinese probe into the UK drugmaker. Most Read from Bloomberg Traders cited a report from the Yicai news service released earlier in the day, with the stock’s losses snowballing during afternoon trading. AstraZeneca…
The office building of biopharmaceutical company AstraZeneca is being seen in Shanghai, China, on May 23, 2024. Nurphoto | Getty Images AstraZeneca‘s China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending shares down as much as 5.3%. It was not immediately clear whether the executive Leon Wang…
(This is CNBC Pro’s live coverage of Friday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to view the latest posts.) A biotech stock and an energy company were among the names being talked about by analysts on Friday. JPMorgan downgraded Moderna to underweight from neutral. Meanwhile, BMO Capital Markets initiated GE…